Role of the Immune Environment in Response to Therapy in Breast Cancer

Clinical trial NCT05396612 · RECRUITING

Trial details

NCT number: NCT05396612
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer ER Positive Breast Cancer HER2-negative Breast Cancer TNBC - Triple-Negative Breast Cancer

Start date: 2022-10-03
Primary completion: 2032-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.